Kimberly-Clark Corp. (0JQZ)
London Exchange · UK · prices in USD · close of 21 Oct 2026
Key indicators
| Last close | USD 107.09 |
|---|---|
| 52-week range | 92.07 – 121.36 |
| Return, 1 month / 3 months | +8.3% / −2.0% |
| Return, 1 year / 3 years | −8.5% / −1.5% |
| Trend | Uptrend |
| RSI (14) | 71 |
| Volatility (1 year) | 28.2% |
| Worst drawdown (1 year) | -23.3% |
| Average daily value traded | 0.32M USD |
| Dividend yield | 1.2% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Kimberly-Clark is a consumer products company based in the United States that makes personal care and tissue products sold in many countries. Its household brands include diapers, baby wipes, facial tissues, toilet paper and paper towels, along with feminine care and adult care items. The company also supplies professional hygiene and safety products such as dispensers, wipes and protective clothing to workplaces, hospitals and other institutions.
On this site Kimberly-Clark Corp. appears as a stock on the London Exchange (UK), code 0JQZ, with prices in US dollars (USD). Our dividend records, which start in 2019, show payments in 7 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Kimberly-Clark Corp. (0JQZ) trades on the London Exchange in UK. It last closed at USD 107.09 on 21 October 2026.
Its price-based Market X-Ray is 53 out of 100 (a fair price profile), ranking 1,912 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 8.5% and over the last three months it fell 2.0%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 57 · Fair | Mixed trend against its averages. | |
| Above 200-day average | 4.2% | ||
| From 52-week high | -10.9% | ||
| Momentum | 45 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -2.0% | ||
| 6-month return | 9.5% | ||
| 12-month return, skipping the last month | -15.5% | ||
| Stability (higher is calmer) | 65 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 28.2% | ||
| Worst drawdown, 1 year (smaller is calmer) | -23.3% | ||
| Liquidity | 41 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.32M USD | ||
| Zero-volume days | 0.0% | ||
| Income | 46 · Weak | Dividend is small or irregular. | |
| Dividend yield | 1.2% | ||
| Years with dividends | 5 |
Strengths
No lens stands out as a clear strength against its exchange.
Weak spots
- Momentum: Lagging most stocks on this exchange.
- Liquidity: Thinly traded: prices can jump and exits can be hard.
- Income: Dividend is small or irregular.
Returns
| 1 week | +8.1% |
|---|---|
| 1 month | +8.3% |
| 3 months | −2.0% |
| 6 months | +9.5% |
| 1 year | −8.5% |
| 3 years | −1.5% |
| 5 years | – |
Signals
| 50-day / 200-day average | 102.79 / 102.80 |
|---|---|
| Golden / death cross (60 days) | Death, 0 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 3.09 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 5 Dec 2025 | USD 1.2600 |
| 4 Sep 2025 | USD 1.2600 |
| 5 Jun 2025 | USD 1.2600 |
| 6 Mar 2025 | USD 1.2600 |
| 6 Dec 2024 | USD 1.2200 |
| 6 Sep 2024 | USD 1.2200 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.